2020, Number S2
<< Back Next >>
Rev Mex Traspl 2020; 9 (S2)
SARS-CoV-2 infection and pediatric transplantation
Martínez HJA, Medeiros M
Language: Spanish
References: 25
Page: 200-205
PDF size: 235.49 Kb.
ABSTRACT
SARS-CoV-2 infection also affects children, most of them acquire the virus by household contact. The COVID-19 disease in general has a benign course in children, with a higher proportion of mild symptoms than adults, nevertheless preliminary reports in Mexico show higher mortality rate in pediatric population than USA and Europe. This finding could be related to the high prevalence of overweight and obesity in Mexican children, and the chronic diseases driven by them such as diabetes and hypertension. The association between COVID-19 and multisystemic inflammatory syndrome was recently described in children with a severe presentation. The SARS-CoV-2 pandemic has special effects in children with kidney chronic diseases, because they have higher risk of bad outcomes and also because of the impact on transplant activity, that in Mexico has been withheld since March 2020, increasing the waitlist time. Transplant recipients are at risk of bad outcomes with COVID-19, since they receive chronic immunosuppression.
REFERENCES
Secretaría de Salud. Conferencia de prensa informe diario sobre coronavirus. Gobierno de México. Disponible en: https://coronavirus.gob.mx/2020/07/29/conferencia-29-de-julio/2020.
Idele PA, Anthony D, Mofenson LM, Requejo J, You D, Luo C et al. The evolving epidemiologic and clinical picture of SARS-CoV-2 and COVID-19 disease in children and young people. UNICEF Office of Research; July 2020. Available in: https://www.unicef-irc.org/publications/pdf/Evolving-Epidemiologic-Clinical-Picture-SARS-CoV2-COVID-19-Children-Young-People.pdf; 2020.
Heald-Sargent T, Muller WJ, Zheng X, Rippe J, Patel AB, Kocioleck LK. Age-related differences in nasopharyngeal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) levels in patients with mild to moderate coronavirus disease 2019 (COVID-19). JAMA Pediatr. 2020.
Rajapakse N, Dixit D. Human and novel coronavirus infections in children: a review. Paediatr Int Child Health. 2020; 1-20.
Hon KL, Leung CW, Cheng WT, Chan PK, Chu WC, Kwan YW et al. Clinical presentations and outcome of severe acute respiratory syndrome in children. Lancet. 2003; 361 (9370): 1701-1703.
Thabet F, Chehab M, Bafaqih H, Al Mohaimeed S. Middle East respiratory syndrome coronavirus in children. Saudi Med J. 2015; 36 (4): 484-486.
Parasa S, Desai M, Thoguluva Chandrasekar V, Patel HK, Kennedy KF, Roesch T et al. Prevalence of gastrointestinal symptoms and fecal viral shedding in patients with coronavirus disease 2019: a systematic review and meta-analysis. JAMA Netw Open. 2020; 3 (6): e2011335.
Wang W, Xu Y, Gao R, Lu R, Han K, Wu G et al. Detection of SARS-CoV-2 in different types of clinical specimens. JAMA. 2020.
Coccolini F, Tartaglia D, Puglisi A, Lodato M, Chiarugi M. SARS-CoV-2 is present in peritoneal fluid in COVID-19 patient. Ann Surg. 2020; 1-4.
Egloff C, Vauloup-Fellous C, Picone O, Mandelbrot L, Roques P. Evidence and possible mechanisms of rare maternal-fetal transmission of SARS-CoV-2. J Clin Virol. 2020; 128: 104447.
Zimmermann P, Curtis N. COVID-19 in children, pregnancy and neonates: a review of epidemiologic and clinical features.Pediatr Infect Dis J. 2020; 39 (6): 355-368.
Sifuentes-Rodriguez E, Palacios-Reyes D. COVID-19: the outbreak caused by a new coronavirus. Bol Med Hosp Infant Mex. 2020; 77 (2): 47-53.
Perez-Herrera A, Cruz-Lopez M. Childhood obesity: current situation in Mexico. Nutr Hosp. 2019; 36 (2): 463-469.
Ramírez-Ramírez FJ, Angulo-Castellanos E, Gutiérrez-Padilla JA, Luévanos-Velásquez A. Epidemiology of pediatric COVID-19 in Mexico: a first sight. Revista Médica MD. 2020; 11 (3): 131-135.
American Academy of Pediatrics. Children and COVID-19: State level data report. 2020. Available in: https://services.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/children-and-covid-19-state-level-data-report/
Gotzinger F, Santiago-Garcia B, Noguera-Julian A, Lanaspa M, Lancella L, Calo Carducci FI et al. COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study. Lancet Child Adolesc Health. 2020.
Vega-Vega O, Arvizu-Hernandez M, Dominguez-Cherit JG, Sierra-Madero J, Correa-Rotter R. Prevention and control of SARS-CoV-2 (Covid-19) coronavirus infection in hemodialysis units. Salud Publica Mex. 2020; 62 (3): 341-347.
Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020; 97 (5): 829-838.
Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990; 86 (4): 1343-1346.
Martinez-Rojas MA, Vega-Vega O, Bobadilla NA. Is the kidney a target of SARS-CoV-2? Am J Physiol Renal Physiol. 2020; 318 (6): F1454-F1462.
Durvasula R, Wellington T, McNamara E, Watnick S. COVID-19 and kidney failure in the acute care setting: our experience from Seattle. Am J Kidney Dis. 2020.
Dufort EM, Koumans EH, Chow EJ, Rosenthal EM, Muse A, Rowlands J et al. Multisystem inflammatory syndrome in children in New York state. N Engl J Med. 2020; 383 (4): 347-358.
Zhao J, Zuo J, Wang X, Lin J, Yang Y, Zhou J et al. GeoChip-based analysis of microbial community of a combined nitritation-anammox reactor treating anaerobic digestion supernatant. Water Res. 2014; 67: 345-354.
Akalin E, Azzi Y, Bartash R, Seethamraju H, Parides M, Hemmige V et al. Covid-19 and kidney transplantation. N Engl J Med. 2020; 382 (25): 2475-2477.
South AM, Brady TM, Flynn JT. ACE2 (angiotensin-converting enzyme 2), COVID-19, and ACE inhibitor and Ang II (angiotensin II) receptor blocker use during the pandemic: the pediatric perspective. Hypertension. 2020; 76 (1): 16-22.
Full text
10.35366/94509